ArticleOncoimmunology2021

Cancer-specific type-I interferon receptor signaling promotes cancer stemness and effector CD8+ T-cell exhaustion.

Wang Gong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.